Scientific Advisory Board
Allen Ebens, B.Sc., Ph.D.
Dr. Allen Ebens completed a PhD at UCLA and Post-doctoral training at UCSF before joining Exelixis as a scientist in the Discovery Biology group. After 6 years with Exelixis Dr. Ebens moved to Genentech where he worked in Research Oncology for 11 years developing therapeutics from concept to clinic across multiple therapeutic platforms including antibodies, small molecule drugs, and antibody-drug conjugates. Dr. Ebens was recruited from Genentech to establish Research Oncology at Juno Therapeutics, and has served more recently as Senior Director of Immune Oncology at NGM Biopharmaceuticals. Dr. Ebens is currently Chief Scientific Officer of Trucode Gene Repair. Over a twenty year career Dr. Ebens’ contributions include significant contributions to the scientific literature as well as advancement of five discovery projects to clinical development.